CLOs on the Move

Mary Free Bed Rehabilitation Hospital

www.maryfreebed.com

 
Mary Free Bed Rehabilitation Hospital is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Mary Free Bed Rehabilitation Hospital is based in Grand Rapids, MI. You can find more information on Mary Free Bed Rehabilitation Hospital at www.maryfreebed.com
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

nTELAGENT

nTELAGENT, Inc is a Brentwood, TN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

RealAge

RealAge is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vitalah

Oxylent has taken the multivitamin category by storm with its award-winning 5-in-1 formula that delivers vitamins, minerals, antioxidants, amino acids and electrolytes in one refreshing drink. Without the use of sugar, gluten, artificial additives, preservatives, dairy, caffeine, binders, or anti-caking agents, Oxylent is known in the market for using only the highest quality ingredients. Oxylent is the only effervescent multivitamin to be awarded Albion’s Gold Medallion, recognizing excellence in mineral formulation. The product contains no sugar and is sweetened with all-natural stevia, a plant-based sweetener that provides the sweetness of sugar without the calories or increase in blood sugar levels. Plus, Oxylent is 100 percent free of gluten, dairy, soy, GMOs and caffeine.

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.

Medical Treatment Systems

Medical Treatment Systems is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.